But Gottlieb’s remarks on establishing greater transparency in FDA decision-making on new drug approvals, and creating new ‘pathways’ for rare disease were probably the most eyecatching for ...

The lawsuit, filed in late 2021, attracted attention after the FDA said it could take decades to process and disclose records to Public Health and Medical Professionals for Transparency ...

Functional and cross-functional teams expect greater data transparency to make compliance easier, which would mitigate the risk of drug supply gaps. Every day that a drug isn't available costs a ...